BYE-LAWS FOR THE DEGREE OF MASTER OF SCIENCE IN PHARMACEUTICAL AND REGULATORY SCIENCES - M.SC. - UNDER THE
Table of Provisions (15)
Statutory Text (15 Articles)
MASTER OF SCIENCE IN PHARMACEUTICAL AND
REGULATORY SCIENCES - M.SC.
SUBSIDIARY LEGISLATION 327.341
BYE-LAWS FOR THE DEGREE OF MASTER OF
SCIENCE IN PHARMACEUTICAL AND
REGULATORY SCIENCES - M.SC. - UNDER THE
AUSPICES OF THE FACULTY OF MEDICINE AND
SURGERY
13th March, 2009
LEGAL NOTICE 66 of 2009, as amended by Legal Notices 489 of 2012,
and 127 and 378 of 2014 and 203 of 2019.
(1) These bye-laws may be cited as the Bye-Laws for the
degree of Master of Science in Pharmaceutical and Regulatory
Sciences - M.Sc. - under the auspices of the Faculty of Medicine
and Surgery.
(2)
In these bye-laws, unless the context otherwise requires –
“the Board” means the Board of the Faculty of Medicine and
Surgery;
“the Course” means the programme of study leading to the
degree of Master of Science in Pharmaceutical and Regulatory
Sciences - M.Sc.;
“the Degree” means the degree of Master of Science in
Pharmaceutical and Regulatory Sciences - M.Sc.;
“the Postgraduate Diploma” means the Postgraduate Diploma in
Pharmaceutical and Regulatory Sciences - P.G. Dip.; and
“the Principal Regulations” means the General Regulations for
University Postgraduate Awards, 2008.
These bye-laws shall be applicable
for
courses
commencing in 1st August 2019 or later.
The course shall be open to applicants in possession of
(a) a Bachelor degree in Pharmacy with at least Second
Class Honours; or
(b) the degree of Master of Pharmacy; or
(c) the degree of Bachelor of Science in Pharmaceutical
Technology with at least Second Class Honours; or
(d) a Bachelor degree with at least Second Class Honours
in any other area of study which the Board deems to be
relevant, or the degree of Doctor of Medicine and
Surgery obtained at least two years prior to registration
in the course, or the degree of Bachelor of Dental
Surgery; or
(e) the degree of Master of Dental Surgery awarded from
July 2018 onwards; or
(f)
a Bachelor degree in Pharmacy or in any other area
MASTER OF SCIENCE IN PHARMACEUTICAL AND
REGULATORY SCIENCES - M.SC.
which the Board deems to be relevant, obtained with
Third Class Honours, if they are also in possession of
other qualifications, including relevant experience,
obtained following the first cycle degree.
The Board shall recommend to Senate the number of
applicants that may be allowed to register for the course, depending
on the availability of resources. The number of available places
shall be announced at the time of the call for applications.
If there are more eligible applicants than the number of
places available, applicants shall be selected after an interview by a
board appointed for the purpose. The board shall select applicants
according to the following criteria
(a) degree type and class;
(b) experience in the area of the proposed study; and
(c) performance during an interview.
The course shall extend over three semesters of full-time
study or the equivalent in part-time study.
The programme of study shall comprise study-units to
which a total of 90 credits are assigned, of which 60 credits are
assigned to the taught study-units and 30 credits are assigned to the
dissertation study-unit.
Students who obtain the 60 credits assigned to the taught
study-units with an average mark of at least 50% and do not
proceed with the course, or having proceeded do not successfully
complete the dissertation, shall be eligible for the award of the
Postgraduate Diploma.
The programme of study shall be published after approval
by Senate, normally not less than eight months prior to the
commencement of the course.
(1) The assessment of each taught study-unit shall be
completed by the end of the semester in which the teaching of the
study-unit is held.
(2) Students who in any academic year fail in the assessment of
not more than 20 credits for taught study-units if following the full-
time course, or not more than 10 credits if following the part-time
course, shall be given the opportunity to re-sit the failed study-
units during the September supplementary examination session.
(3) Students who fail in more than the number of credits
permitted under paragraph (2) or students who after re-assessment
fail to obtain the credits for any study-unit, shall be deemed to have
failed the course.
(1) Students shall be required to submit an individual
dissertation of approximately 25,000 words in accordance with the
guidelines issued by the Board.
(2) Work on the dissertation shall be undertaken during the
third semester of the course. Each student shall be assigned a
MASTER OF SCIENCE IN PHARMACEUTICAL AND
REGULATORY SCIENCES - M.SC.
supervisor who shall provide guidance and advice on a regular
basis during the period of study.
(3) A provisional title for the dissertation and a detailed
research proposal shall be submitted to the Board for approval by
the beginning of the second semester.
(1) Students shall be required to have regular contact with
their supervisor.
(2) Supervisors shall submit to the Board progress reports for
each student under their supervision at the end of each semester of
studies, whether the student is following the course on a full-time
or a part-time basis. Such reports may include a recommendation to
either (a) extend the period of study in order to enable the student
to complete the dissertation; or (b) terminate studies prematurely if
the supervisor deems this to be proper in the circumstances,
provided that
(i)
the extension of the study period referred to in (a)
shall be in accordance with the provisions of the
Principal Regulations; and
(ii) the Board may not terminate studies prematurely
according to (b) until it has first given the student a
chance to be heard.
The Final Weighted Average Mark for the purpose of the
classification of the Postgraduate Diploma and of the Degree shall
be based on the results obtained in all the components of the
programme of study, all credits being weighted equally.
The provisions of the foregoing bye-laws shall apply
mutatis mutandis to courses followed on a part-time basis, and
subject to such changes as may reasonably be deemed by the
relevant Board as necessary due to the part-time nature of the
course.